Cargando…

Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography

Alzheimer’s disease (AD) is characterized by formation of amyloid plaques and neurofibrillary tangles in the brain, which can be mimicked by transgenic mouse models. Here, we report on the characterization of amyloid load in the brains of two transgenic amyloidosis models using positron emission tom...

Descripción completa

Detalles Bibliográficos
Autores principales: Willuweit, Antje, Schöneck, Michael, Schemmert, Sarah, Lohmann, Philipp, Bremen, Saskia, Honold, Dominik, Burda, Nicole, Jiang, Nan, Beer, Simone, Ermert, Johannes, Willbold, Dieter, Shah, N. Jon, Langen, Karl-Josef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520975/
https://www.ncbi.nlm.nih.gov/pubmed/34671235
http://dx.doi.org/10.3389/fnins.2021.699926
_version_ 1784584798789959680
author Willuweit, Antje
Schöneck, Michael
Schemmert, Sarah
Lohmann, Philipp
Bremen, Saskia
Honold, Dominik
Burda, Nicole
Jiang, Nan
Beer, Simone
Ermert, Johannes
Willbold, Dieter
Shah, N. Jon
Langen, Karl-Josef
author_facet Willuweit, Antje
Schöneck, Michael
Schemmert, Sarah
Lohmann, Philipp
Bremen, Saskia
Honold, Dominik
Burda, Nicole
Jiang, Nan
Beer, Simone
Ermert, Johannes
Willbold, Dieter
Shah, N. Jon
Langen, Karl-Josef
author_sort Willuweit, Antje
collection PubMed
description Alzheimer’s disease (AD) is characterized by formation of amyloid plaques and neurofibrillary tangles in the brain, which can be mimicked by transgenic mouse models. Here, we report on the characterization of amyloid load in the brains of two transgenic amyloidosis models using positron emission tomography (PET) with florbetaben (FBB), an (18)F-labeled amyloid PET tracer routinely used in AD patients. Young, middle-aged, and old homozygous APP/PS1 mice (ARTE10), old hemizygous APPswe/PS1ΔE9, and old wild-type control mice were subjected to FBB PET using a small animal PET/computed tomography scanner. After PET, brains were excised, and ex vivo autoradiography was performed. Plaque pathology was verified on brain sections with histological methods. Amyloid plaque load increased progressively with age in the cortex and hippocampus of ARTE10 mice, which could be detected with both in vivo FBB PET and ex vivo autoradiography. FBB retention showed significant differences to wild-type controls already at 9 months of age by both in vivo and ex vivo analyses. An excellent correlation between data derived from PET and autoradiography could be obtained (r(Pearson) = 0.947, p < 0.0001). Although amyloid load detected by FBB in the brains of old APPswe/PS1ΔE9 mice was as low as values obtained with young ARTE10 mice, statistically significant discrimination to wild-type animals was reached (p < 0.01). In comparison to amyloid burden quantified by histological analysis, FBB retention correlated best with total plaque load and number of congophilic plaques in the brains of both mouse models. In conclusion, the homozygous ARTE10 mouse model showed superior properties over APPswe/PS1ΔE9 mice for FBB small animal amyloid PET imaging. The absolute amount of congophilic dense-cored plaques seems to be the decisive factor for feasibility of amyloidosis models for amyloid PET analysis.
format Online
Article
Text
id pubmed-8520975
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85209752021-10-19 Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography Willuweit, Antje Schöneck, Michael Schemmert, Sarah Lohmann, Philipp Bremen, Saskia Honold, Dominik Burda, Nicole Jiang, Nan Beer, Simone Ermert, Johannes Willbold, Dieter Shah, N. Jon Langen, Karl-Josef Front Neurosci Neuroscience Alzheimer’s disease (AD) is characterized by formation of amyloid plaques and neurofibrillary tangles in the brain, which can be mimicked by transgenic mouse models. Here, we report on the characterization of amyloid load in the brains of two transgenic amyloidosis models using positron emission tomography (PET) with florbetaben (FBB), an (18)F-labeled amyloid PET tracer routinely used in AD patients. Young, middle-aged, and old homozygous APP/PS1 mice (ARTE10), old hemizygous APPswe/PS1ΔE9, and old wild-type control mice were subjected to FBB PET using a small animal PET/computed tomography scanner. After PET, brains were excised, and ex vivo autoradiography was performed. Plaque pathology was verified on brain sections with histological methods. Amyloid plaque load increased progressively with age in the cortex and hippocampus of ARTE10 mice, which could be detected with both in vivo FBB PET and ex vivo autoradiography. FBB retention showed significant differences to wild-type controls already at 9 months of age by both in vivo and ex vivo analyses. An excellent correlation between data derived from PET and autoradiography could be obtained (r(Pearson) = 0.947, p < 0.0001). Although amyloid load detected by FBB in the brains of old APPswe/PS1ΔE9 mice was as low as values obtained with young ARTE10 mice, statistically significant discrimination to wild-type animals was reached (p < 0.01). In comparison to amyloid burden quantified by histological analysis, FBB retention correlated best with total plaque load and number of congophilic plaques in the brains of both mouse models. In conclusion, the homozygous ARTE10 mouse model showed superior properties over APPswe/PS1ΔE9 mice for FBB small animal amyloid PET imaging. The absolute amount of congophilic dense-cored plaques seems to be the decisive factor for feasibility of amyloidosis models for amyloid PET analysis. Frontiers Media S.A. 2021-10-04 /pmc/articles/PMC8520975/ /pubmed/34671235 http://dx.doi.org/10.3389/fnins.2021.699926 Text en Copyright © 2021 Willuweit, Schöneck, Schemmert, Lohmann, Bremen, Honold, Burda, Jiang, Beer, Ermert, Willbold, Shah and Langen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Willuweit, Antje
Schöneck, Michael
Schemmert, Sarah
Lohmann, Philipp
Bremen, Saskia
Honold, Dominik
Burda, Nicole
Jiang, Nan
Beer, Simone
Ermert, Johannes
Willbold, Dieter
Shah, N. Jon
Langen, Karl-Josef
Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_full Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_fullStr Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_full_unstemmed Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_short Comparison of the Amyloid Load in the Brains of Two Transgenic Alzheimer’s Disease Mouse Models Quantified by Florbetaben Positron Emission Tomography
title_sort comparison of the amyloid load in the brains of two transgenic alzheimer’s disease mouse models quantified by florbetaben positron emission tomography
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520975/
https://www.ncbi.nlm.nih.gov/pubmed/34671235
http://dx.doi.org/10.3389/fnins.2021.699926
work_keys_str_mv AT willuweitantje comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT schoneckmichael comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT schemmertsarah comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT lohmannphilipp comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT bremensaskia comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT honolddominik comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT burdanicole comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT jiangnan comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT beersimone comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT ermertjohannes comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT willbolddieter comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT shahnjon comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography
AT langenkarljosef comparisonoftheamyloidloadinthebrainsoftwotransgenicalzheimersdiseasemousemodelsquantifiedbyflorbetabenpositronemissiontomography